P. Camus (Dijon, France), A. Browatzki (Copenhagen, Denmark)
Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality R. T. M. Sprooten, R. H. J. Slenter, D. Kotz, G. Wesselig, E. F. M. Wouters, G. G. U. Rohde (Maastricht, Netherlands)
| |
On relationship between local and systemic chronic inflammation and between level of hypoxia and bronchial obstruction in COPD pts B. Basina, T. Pertseva, L. Konopkina (Dnipropetrovsk, Ukraine)
| |
Vitamin D, exacerbations and hospitalizations in COPD patients M. Bellocchia, M. Masoero, A. Vaudano, A. Ciuffreda, A. Malinovschi, C. Bucca (Turin, Italy; Uppsala, Sweden)
| |
Balance control in chronic obstructive pulmonary disease: Does breathing disturb balance? P. Hodges, M. Smith (Brisbane, Australia)
| |
Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years G. Lundgren, F. Ramos, L. Ribeiro, F. Lundgren (Recife, Brazil)
| |
Evolution of quality of life (CAT and CCQ) after a COPD exacerbation M. J. Espinosa de los Monteros, P. García-Sidro, A. Fernández-Nistal, M. J. Buendía, J. Molina, M. Miravitlles (Toledo, Castellón, Madrid, Barcelona, Spain)
| |
Comparison of the administration of COPD assessment test by face-to-face interview versus telephone interview: A randomized trial E. Pereira, G. Silva, M. T. Morano, C. Viana, G. Matos, C. Magalhães (Fortaleza, Brazil)
| |
The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis V. Kapustina, S. Ovcharenko (Moscow, Russian Federation)
| |
High risk COPD patients cost less if treated according to GOLD 2011 recommendations N. Yanev, N. Kyuchukov, P. Nikolova, P. Pavlov, T. Popova, I. Krachunov, Y. Ivanov (Pleven, Bulgaria)
| |
High rate of obstructive pulmonary function tests in adults below 40 Years of age in Germany R. Wiewrodt, B. Hoepfner, L. H. Schmist, K. Blackert, F. J. F. Herth (Muenster, Werne, Heidelberg, Germany)
| |
Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) O. Mardanova, V. T. Ivashkin (Moscow, Russian Federation)
| |
Mental disorders prevalence in COPD patients Y. Galetskayte, D. Pushkarev, S. Ovcharenko, B. Volel, A. Andrushenko, N. Zaharova (Moscow, Russian Federation)
| |
Hypoxemia as a risk factor for endothelial dysfunction in COPD patients M. Makarova, S. Avdeev, A. Chuchalin (Moscow, Russian Federation)
| |
Systemic inflammation in patients with chronic obstructive pulmonary disease N. Sanina, T. Pertseva, S. Panina (Dnipropetrovs'k, Ukraine)
| |
COPD care programme can reduce readmissions and in-patient bed days F. W. S. Ko, M. Y. Leung, M. C. Pun, J. C. N. Ngai, A. H. M. Tung, S. S. S. Ng, R. Cheung, T. O. Chan, P. Y. Chan, D. S. C. Hui (Hong Kong, Hong Kong)
| |
Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients V. Kobylyanskiy, E. Soyustova, T. Turusina, G. Babadzhanova, E. Musalevskay, Y. Suntsov (Moscow, Russian Federation)
| |
Thoracic determination of Behçet's disease W. Elkhattabi, A. Aichane, H. Jabri, R. Bopaka, H. Afif, Z. Bouayad (Casablanca, Morocco)
| |
The effect of folic acid supplementation on hyperhomocysteinemia and pulmonary function parameters in chronic obstructive pulmonary disease M. Daga, N. Khan, H. Saini (New Delhi, India)
| |